Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Gene therapy: an alternative to treat Alzheimer's disease.
Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec 11. doi: 10.1007/s00210-023-02873-z. Online ahead of print.
Naunyn Schmiedebergs Arch Pharmacol. 2023.
PMID: 38078920
Review.
According to the age at which it manifests in a person, there are two subtypes of AD: 'LOAD (Late Onset Alzheimer's Disease)' and 'EOAD (Early Onset Alzheimer's Disease)'. Long-term research into AD treatment has resulted in the introduction of some medications that provid …
According to the age at which it manifests in a person, there are two subtypes of AD: 'LOAD (Late Onset Alzheimer's Disease)' and 'EOAD (Ear …
Transcutaneous Bilirubin Nomogram for Healthy Term and Late Preterm Neonates in First 96 Hours of Life.
Thakkar P, Chavda H, Doshi V.
Thakkar P, et al. Among authors: doshi v.
Indian Pediatr. 2017 May 15;54(5):369-372. doi: 10.1007/s13312-017-1108-0. Epub 2017 Mar 29.
Indian Pediatr. 2017.
PMID: 28368263
Free article.
BACKGROUND: To develop nomogram of Transcutaneous Bilirubin among healthy term and late-preterm neonates during first 96 hours of age. DESIGN: Longitudinal observational study. SETTING: Neonatal unit of a tertiary care Hospital of Central Gujarat, India. PARTICIPANTS: 1075 …
BACKGROUND: To develop nomogram of Transcutaneous Bilirubin among healthy term and late-preterm neonates during first 96 hours of age …
Item in Clipboard
Cite
Cite